Lilly plans new $2.5B manufacturing plant as obesity drug demand ramps up
BioPharma
Stay updated with breaking news from David Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Closely watched clinical trial could help boost insurance coverage of GLP-1 drugs, analysts say
Deutsche Bank analyst James Shin says there are several reasons why Lilly should trade at a premium to Novo Nordisk.
Indiana gubernatorial candidate Brad Chambers’ campaign is likely to receive tens of thousands of dollars from an upcoming fundraiser hosted by racing legend Michael Andretti, adding to the Republican hopeful’s
It’s part of a new class of drugs that includes semaglutide, known as Ozempic for diabetes and Wegovy for weight loss, which have skyrocketed in popularity in recent years.